Frisch Financial Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.2M | Buy |
9,241
+2
| +0% | +$234 | 0.21% | 68 |
|
|
2026
Q1 | $1.12M | Buy |
9,239
+40
| +0.4% | +$4.62K | 0.23% | 60 |
|
|
2025
Q4 | $976K | Sell |
9,199
-356
| -4% | -$33.4K | 0.22% | 63 |
|
|
2025
Q3 | $810K | Buy |
9,555
+396
| +4% | +$32.6K | 0.19% | 66 |
|
|
2025
Q2 | $732K | Buy |
9,159
+115
| +1% | +$9.14K | 0.18% | 66 |
|
|
2025
Q1 | $819K | Buy |
9,044
+77
| +0.9% | +$7.19K | 0.23% | 54 |
|
|
2024
Q4 | $899K | Buy |
8,967
+43
| +0.5% | +$4.43K | 0.27% | 49 |
|
|
2024
Q3 | $1.02M | Buy |
8,924
+436
| +5% | +$51.8K | 0.31% | 45 |
|
|
2024
Q2 | $1.05M | Sell |
8,488
-75
| -0.9% | -$9.66K | 0.32% | 42 |
|
|
2024
Q1 | $1.13M | Buy |
8,563
+140
| +2% | +$17.3K | 0.38% | 35 |
|
|
2023
Q4 | $918K | Sell |
8,423
-59
| -0.7% | -$6.12K | 0.35% | 44 |
|
|
2023
Q3 | $873K | Sell |
8,482
-293
| -3% | -$31.6K | 0.35% | 42 |
|
|
2023
Q2 | $1.01M | Buy |
8,775
+281
| +3% | +$31.9K | 0.49% | 37 |
|
|
2023
Q1 | $904K | Buy |
8,494
+240
| +3% | +$25.9K | 0.35% | 45 |
|
|
2022
Q4 | $916K | Sell |
8,254
-106
| -1% | -$10.8K | 0.34% | 50 |
|
|
2022
Q3 | $720K | Sell |
8,360
-18
| -0.2% | -$1.61K | 0.31% | 50 |
|
|
2022
Q2 | $764K | Buy |
8,378
+50
| +0.6% | +$4.43K | 0.3% | 50 |
|
|
2022
Q1 | $683K | Sell |
8,328
-869
| -9% | -$68.5K | 0.22% | 64 |
|
|
2021
Q4 | $704K | Buy |
9,197
+457
| +5% | +$36.4K | 0.22% | 67 |
|
|
2021
Q3 | $656K | Sell |
8,740
-332
| -4% | -$25.3K | 0.22% | 64 |
|
|
2021
Q2 | $705K | Sell |
9,072
-558
| -6% | -$41.5K | 0.22% | 61 |
|
|
2021
Q1 | $709K | Buy |
9,630
+71
| +0.7% | +$5.24K | 0.24% | 60 |
|
|
2020
Q4 | $746K | Sell |
9,559
-5,341
| -36% | -$408K | 0.27% | 49 |
|
|
2020
Q3 | $1.18M | Buy |
14,900
+4,687
| +46% | +$367K | 0.51% | 32 |
|
|
2020
Q2 | $754K | Buy |
10,213
+2,377
| +30% | +$179K | 0.36% | 37 |
|
|
2020
Q1 | $575K | Sell |
7,836
-3,945
| -33% | -$310K | 0.33% | 44 |
|
|
2019
Q4 | $1.02M | Buy |
11,781
+4,179
| +55% | +$343K | 0.48% | 35 |
|
|
2019
Q3 | $611K | Buy |
7,602
+3,789
| +99% | +$304K | 0.37% | 44 |
|
|
2019
Q2 | $305K | Sell |
3,813
-3,940
| -51% | -$302K | 0.2% | 66 |
|
|
2019
Q1 | $615K | Buy |
7,753
+3,922
| +102% | +$293K | 0.38% | 50 |
|
|
2018
Q4 | $279K | Buy |
+3,831
| New | +$270K | 0.2% | 71 |
|
Other funds holding MRK
Frisch Financial Group's MRK Position: Q2 2026 in Review
Frisch Financial Group increased its Merck (MRK) stake by 0.02% in Q2 2026, buying an estimated $234 and bringing the position to 9,241 shares worth $1.2M. The position accounts for 0.21% of the portfolio, ranked #68.
Frisch Financial Group first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Frisch Financial Group held 9,241 shares of Merck worth $1.2M as of Q2 2026.
- Frisch Financial Group bought 2 Merck shares in Q2 2026, an estimated $234.
- Merck made up 0.21% of Frisch Financial Group's portfolio in Q2 2026, its #68 holding.
- Frisch Financial Group first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Frisch Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.